Additionally, organoids generated from chordoma patients have also been shown to contain both PD-L1-positive tumor cells and PD-1/CD8-positive lymphocytes, and they displayed a marked response to nivolumab treatment (124). The gene discussed is CD274; the disease is chordoma.